Danforth Advisors provides strategic and operational support to life sciences companies, offering services in operational finance, strategic communications, risk management, and human resources, self-described as tailored and flexible.

Danforth Advisors

Biotechgate provides information and solutions for the life sciences industry, including databases for clinical trials and investor connections. The service offers access to business development and licensing information self-described as comprehensive.

Biotechgate

Danforth Advisors | 5,434 followers on LinkedIn. Life Sciences, Well Run | Danforth is the life science industry’s trusted partner for strategic and operational support across corporate, clinical, and commercial functions. The company advises and executes in the areas of finance and accounting, strategic communications, human resources, risk management, clinical and regulatory, and commercial readiness and launch. Founded in 2011, Danforth has partnered with more than 1,000 life science companies, private and public, across all stages of the corporate lifecycle.

Valeria Escobari

John Hallinan

Strategic HR Consultant at Danforth Advisors

Janice Clements-Skelton (she/her/hers)

Retired

Martha M. Denyer, MBA

Headed to Jefferies London? So are we. Biotech #investors and #leaders interested in connecting with Argot can schedule a meeting by contacting info@argotpartners.com . Hope to see you there!

Argot Partners

Get your clinical trial back on track with guidance from Elite BioPharma Consulting , a Danforth Advisors company.

Congratulations to our client Axonis Therapeutics on emerging from stealth with $115M in Series A financing!

Together with our teammates at Elite BioPharma Consulting , we're proud to support the innovators whose research and development has the potential to combat breast cancer and bring hope to those impacted around the world. #breastcancerawareness

There's still time to register for tomorrow's webinar on pay transparency and compensation planning! Join our discussion with legal, HR and compensation benchmarking experts for actionable insights. Register: https://lnkd.in/extDAFDq Moderated by Ann Darda , the panel will include Suzanne King , Zachary Esrig , and Janice Clements-Skelton (she/her/hers) . #paytransparency #compensation

Twelve states have pay transparency laws in place or pending, with more to follow. Is your organization prepared? Join our discussion with legal, HR and compensation benchmarking experts for actionable insights. Register: https://lnkd.in/extDAFDq Moderated by Ann Darda , the panel will include Suzanne King , Zachary Esrig , and Janice Clements-Skelton (she/her/hers) . #paytransparency #compensation

𝗪𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗣𝗢 𝘄𝗶𝗻𝗱𝗼𝘄? 𝗗𝗼 𝘁𝗵𝗶𝘀 𝗶𝗻𝘀𝘁𝗲𝗮𝗱. In our first edition of 𝘽𝙧𝙚𝙖𝙠𝙞𝙣𝙜 𝘽𝙖𝙙 𝘽𝙞𝙤𝙩𝙚𝙘𝙝, Danforth's Gregg Beloff offers guidance for #biotech CEOs to maximize optionality. "You can’t control scientific outcomes or the markets, but you can take action to ensure your business is operating on its front foot – ready for any potential scenario. By doing so, you give the company all-important 𝘭𝘦𝘷𝘦𝘳𝘢𝘨𝘦 – not just to leap when the time comes, but to leap in the right direction."

In clinical trials, time is money—and delays can cost more than just dollars. If your trial isn't meeting enrollment or timeline goals, acting quickly and strategically is crucial. Learn more here: https://lnkd.in/eKcASHcS Discover how conducting study “health checks,” engaging the right specialized consultants, and implementing proactive, collaborative strategies can turn things around. Talk to Elite BioPharma Consulting about how to navigate these challenges to keep your trial on track. #ClinicalTrials #ClinicalOperations #ClinicalResearch #Biopharma #CRO #Consulting #ClinicalDevelopment #EliteBiopharma #DanforthAdvisors #LifeSciences #ClinicalTrialManagement

To our friends in the San Diego life science community: join us next Wednesday for cocktails and conversation at the Life Sciences Fall Mixer, co-hosted by Danforth, Savills , and CREO . Contact Dan Dehner or click here to reserve your spot! https://lnkd.in/evx7ygxb 📅 Date: Wednesday, October 9th ⏰ Time: 5:30-8:30 PM PT 📍 Location: Del Mar, CA

Metric
Company Name	Danforth Advisors	Biotechgate
Symbol
MSH ID	COM:DANFORTHADVISORS	COM:BIOTECHGATE
Market	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Commercial & Professional Services
Industry	Consulting	Life Sciences
Country	US	CH
Stage	Private Equity Round
Employee Count
Website	danforthadvisors.com	biotechgate.com
LinkedIn	danforth-advisors	biotechgate
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.31K	2.80K
Web Traffic Growth	0.84	2.27
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

DANF

COM:DANFORTHADVISORS

Danforth Advisors

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue